Substitution of Human Papillomavirus Type 16 L2 Neutralizing Epitopes Into L1 Surface Loops: The Effect on Virus-Like Particle Assembly and Immunogenicity
出版年份 2019 全文链接
标题
Substitution of Human Papillomavirus Type 16 L2 Neutralizing Epitopes Into L1 Surface Loops: The Effect on Virus-Like Particle Assembly and Immunogenicity
作者
关键词
-
出版物
Frontiers in Plant Science
Volume 10, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2019-06-21
DOI
10.3389/fpls.2019.00779
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Explanations for the high potency of HPV prophylactic vaccines
- (2018) John Schiller et al. VACCINE
- Displaying 31RG-1 peptide on the surface of HPV16 L1 by use of a human papillomavirus chimeric virus-like particle induces cross-neutralizing antibody responses in mice
- (2018) Xue Chen et al. Human Vaccines & Immunotherapeutics
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial
- (2017) Warner K Huh et al. LANCET
- Developments in L2-based human papillomavirus (HPV) vaccines
- (2017) Christina Schellenbacher et al. VIRUS RESEARCH
- Chimeric L2-Based Virus-Like Particle (VLP) Vaccines Targeting Cutaneous Human Papillomaviruses (HPV)
- (2017) Bettina Huber et al. PLoS One
- Abstract 2367: cGMP production of a chimeric virus-like particle vaccine for prevention of HPV-associated cancers
- (2016) George W. Buchman et al. CANCER RESEARCH
- A human monoclonal antibody against HPV16 recognizes an immunodominant and neutralizing epitope partially overlapping with that of H16.V5
- (2016) Lin Xia et al. Scientific Reports
- The DE and FG loops of the HPV major capsid protein contribute to the epitopes of vaccine-induced cross-neutralising antibodies
- (2016) Sara L. Bissett et al. Scientific Reports
- A Chimeric 18L1-45RG1 Virus-Like Particle Vaccine Cross-Protects against Oncogenic Alpha-7 Human Papillomavirus Types
- (2015) Bettina Huber et al. PLoS One
- Virus-Like Display of a Neo-Self Antigen Reverses B Cell Anergy in a B Cell Receptor Transgenic Mouse Model
- (2014) Bryce Chackerian et al. JOURNAL OF IMMUNOLOGY
- A Cryo-Electron Microscopy Study Identifies the Complete H16.V5 Epitope and Reveals Global Conformational Changes Initiated by Binding of the Neutralizing Antibody Fragment
- (2014) Hyunwook Lee et al. JOURNAL OF VIROLOGY
- Pre-clinical immunogenicity of human papillomavirus alpha-7 and alpha-9 major capsid proteins
- (2014) Sara L. Bissett et al. VACCINE
- Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine
- (2014) Paulo S Naud et al. Human Vaccines & Immunotherapeutics
- Development of human papillomavirus chimaeric L1/L2 candidate vaccines
- (2013) Marieta McGrath et al. ARCHIVES OF VIROLOGY
- Efficacy of RG1-VLP Vaccination against Infections with Genital and Cutaneous Human Papillomaviruses
- (2013) Christina Schellenbacher et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Immunogenic assessment of plant-produced human papillomavirus type 16 L1/L2 chimaeras
- (2013) Catherine B. Pineo et al. PLANT BIOTECHNOLOGY JOURNAL
- Optimization of Multimeric Human Papillomavirus L2 Vaccines
- (2013) Subhashini Jagu et al. PLoS One
- Kinetics and Mechanisms of Thiol–Disulfide Exchange Covering Direct Substitution and Thiol Oxidation-Mediated Pathways
- (2012) Péter Nagy ANTIOXIDANTS & REDOX SIGNALING
- A Human Papillomavirus (HPV)In VitroNeutralization Assay That Recapitulates theIn VitroProcess of Infection Provides a Sensitive Measure of HPV L2 Infection-Inhibiting Antibodies
- (2012) Patricia M. Day et al. Clinical and Vaccine Immunology
- Global burden of cancers attributable to infections in 2008: a review and synthetic analysis
- (2012) Catherine de Martel et al. LANCET ONCOLOGY
- Multi-Analyte Network Markers for Tumor Prognosis
- (2012) Jongkwang Kim et al. PLoS One
- Efficient production of chimeric Human papillomavirus 16 L1 protein bearing the M2e influenza epitope in Nicotiana benthamiana plants
- (2011) Slavica Matić et al. BMC BIOTECHNOLOGY
- Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
- (2010) Silvia de Sanjose et al. LANCET ONCOLOGY
- Plant-made vaccines for humans and animals
- (2010) Edward P. Rybicki PLANT BIOTECHNOLOGY JOURNAL
- Replication and Assembly of Human Papillomaviruses
- (2009) M.J. Conway et al. JOURNAL OF DENTAL RESEARCH
- Chimeric L1-L2 Virus-Like Particles as Potential Broad-Spectrum Human Papillomavirus Vaccines
- (2009) C. Schellenbacher et al. JOURNAL OF VIROLOGY
- High level protein expression in plants through the use of a novel autonomously replicating geminivirus shuttle vector
- (2009) Guy L. Regnard et al. PLANT BIOTECHNOLOGY JOURNAL
- The initial steps leading to papillomavirus infection occur on the basement membrane prior to cell surface binding
- (2009) R. C. Kines et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An HPV 16 L1-based chimeric human papilloma virus-like particles containing a string of epitopes produced in plants is able to elicit humoral and cytotoxic T-cell activity in mice
- (2009) Georgina De la Rosa et al. Virology Journal
- Prevalence, Acquisition, and Clearance of Cervical Human Papillomavirus Infection among Women with Normal Cytology: Hawaii Human Papillomavirus Cohort Study
- (2008) Marc T. Goodman et al. CANCER RESEARCH
- Modification of human papillomavirus-like particle vaccine by insertion of the cross-reactive L2-epitopes
- (2008) Kazunari Kondo et al. JOURNAL OF MEDICAL VIROLOGY
- Arrangement of L2 within the Papillomavirus Capsid
- (2008) C. B. Buck et al. JOURNAL OF VIROLOGY
- Human papillomavirus L1 protein expressed in tobacco chloroplasts self-assembles into virus-like particles that are highly immunogenic
- (2008) Alicia Fernández-San Millán et al. PLANT BIOTECHNOLOGY JOURNAL
- Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2
- (2008) H. H. Alphs et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Evolutionary and structural analyses of alpha-papillomavirus capsid proteins yields novel insights into L2 structure and interaction with L1
- (2008) John Lowe et al. Virology Journal
- T cell responses generated by HIV vaccines in clinical trials
- (2008) Stephen D De Rosa et al. Current Opinion in HIV and AIDS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now